Published on 26/07/2010
Private medical cover may prove useful for the 7,530 women in the UK who develop womb
cancer each year.
That is the current rate of diagnosis of the disease according to new figures from Cancer Research UK – the highest it has been for over 30 years.
It equates to more than 19 women in every 100,000 developing womb cancer, compared to just 13 in every 100,000 in 1975.
Contributing to this is a growing obesity problem among women and a tendency to have fewer children, say experts.
Sara Hiom, Cancer Research UK's director of health information, said: "These figures show that we're still seeing a year on year rise in the number of women diagnosed with womb cancer and more needs to be done to tackle this.
"Women can reduce their risk of developing the disease by keeping a healthy weight and taking regular exercise."
A recent study found that women who are obese during pregnancy are more likely to give birth prematurely.
© ActiveQuote Health Ltd. 2010
Categories: Medical
Related Health Insurance News Articles
02/02/2012Prostate cancer drug Abiraterone turned down by NICE, but available for patients with private medical coverAbiraterone, a drug that extends the life of prostate cancer sufferers, has been provisionally rejected for use on the NHS. However, it will still be available to patients with private medical insurance . ...
03/02/2012Bupa, AXA PPP, WPA and Aviva will cover prostate cancer drug AbirateroneAfter we previously reported that prostate cancer drug abiraterone has been deemed by NICE as too expensive for use on the NHS, health insurers are now coming forward to offer cover for the drug. NICE had...
08/02/2012Hospital superbug C. difficle source is unclear, say scientistsScientists cannot explain how 75 per cent of people catch the superbug C. difficile, after a study showed that only a quarter of infections in one hospital system were traced to contact with a suffering...
09/02/2012Coronary heart disease gene is passed from father to sonUp to one in five men is carrying a gene from their father that increases their risk of coronary heart disease by 50 per cent. A study has found that men can inherit a form of heart disease from their father...
09/02/2012Fasting paired with chemotherapy significantly slows the growth of cancer cellsAn interesting new study indicates that starvation paired with chemotherapy can significantly reduce the growth of cancer cells, matching or improving the effects of chemotherapy alone. Scientists at the...